Log in to save to my catalogue

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC int...

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC int...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_11d8cecf2b5d4cb8a1e0c970a7172a60

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage

About this item

Full title

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-11, Vol.13 (1), p.20739-20739, Article 20739

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

It is difficult to determine whether an individual therapy contributes to the elongation of survival because of the difficulty of organizing clinical research in patients who receive multiple treatments in HCC. We aimed to establish a new model of survival prediction in patients with intermediate stage HCC to establish standards in the recent and c...

Alternative Titles

Full title

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_11d8cecf2b5d4cb8a1e0c970a7172a60

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_11d8cecf2b5d4cb8a1e0c970a7172a60

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-48068-7

How to access this item